Clinical trials are important for patients, they are beneficial to the NHS and they are good for the UK economy.
MMIP represents the voice of medicines manufacturers in the UK. It was established jointly by the Government and the biopharmaceutical industry in 2014 to ensure that the UK is recognised by the global medicines industry as a world-class advanced centre for medicines manufacturing.
The UK biopharmaceutical industry has a long and proud record of high quality, reliable manufacturing of medicinal products The UK medicines industry is one of our leading manufacturing sectors, with exports worth £24 billion and generating a trade surplus of £4.9 billion in 2012.
Research involving animals is a vital part of biomedical research and medicine development, helping us to understand and improve the prevention and treatment of diseases in animals and humans.
Clinical trials are the cornerstone of the research and development process and it is through trials that pharmaceutical companies are able to demonstrate the safety and efficacy of new medicines.
